Hepatic and kidney uptake of soluble monomeric and polymeric IgA aggregates. 1984

J Sancho, and E González, and F Rivera, and J F Escanero, and J Egido

To investigate the handling of IgA by the mononuclear phagocytic system and by hepatocytes of mice, soluble, similar sized, heat-aggregated monomeric (A-mIgA) and polymeric IgA (ApIgA) were used as akin to IgA immune complexes. The half-life of the clearance from circulation decreased from 2.5 hr to 4.2 min and from 22 min to 1.8 min after aggregation of mIgA and pIgA, respectively. Tissue localization experiments indicated that the liver was the organ predominantly involved in the uptake and catabolism of the proteins injected. The rate of the liver catabolism and/or elimination of aggregated polymeric IgA was the slowest up to 24 hr of injection. Aggregated pIgA was deposited in the kidney in larger amounts than aggregated mIgA. The participation of hepatocytes and nonparenchymal liver cells was determined after isolation and purification of these cells. The four substances injected, pIgA, A-pIgA, mIgA and A-mIgA, were predominantly localized in nonparenchymal cells when the uptake was expressed per volume of cells, due to their lower protein content. However, when the results were expressed cell to cell there was a high ratio of IgA aggregates associated with hepatocytes to nonparenchymal cells. It seems probable, therefore, that hepatocytes are almost exclusively responsible for clearance of IgA aggregates from blood.

UI MeSH Term Description Entries
D007070 Immunoglobulin A Represents 15-20% of the human serum immunoglobulins, mostly as the 4-chain polymer in humans or dimer in other mammals. Secretory IgA (IMMUNOGLOBULIN A, SECRETORY) is the main immunoglobulin in secretions. IgA,IgA Antibody,IgA1,IgA2,Antibody, IgA
D007668 Kidney Body organ that filters blood for the secretion of URINE and that regulates ion concentrations. Kidneys
D008099 Liver A large lobed glandular organ in the abdomen of vertebrates that is responsible for detoxification, metabolism, synthesis and storage of various substances. Livers
D008813 Mice, Inbred ICR An inbred strain of mouse that is used as a general purpose research strain, for therapeutic drug testing, and for the genetic analysis of CARCINOGEN-induced COLON CANCER. Mice, Inbred ICRC,Mice, ICR,Mouse, ICR,Mouse, Inbred ICR,Mouse, Inbred ICRC,ICR Mice,ICR Mice, Inbred,ICR Mouse,ICR Mouse, Inbred,ICRC Mice, Inbred,ICRC Mouse, Inbred,Inbred ICR Mice,Inbred ICR Mouse,Inbred ICRC Mice,Inbred ICRC Mouse
D002469 Cell Separation Techniques for separating distinct populations of cells. Cell Isolation,Cell Segregation,Isolation, Cell,Cell Isolations,Cell Segregations,Cell Separations,Isolations, Cell,Segregation, Cell,Segregations, Cell,Separation, Cell,Separations, Cell
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D000936 Antigen-Antibody Complex The complex formed by the binding of antigen and antibody molecules. The deposition of large antigen-antibody complexes leading to tissue damage causes IMMUNE COMPLEX DISEASES. Immune Complex,Antigen-Antibody Complexes,Immune Complexes,Antigen Antibody Complex,Antigen Antibody Complexes,Complex, Antigen-Antibody,Complex, Immune,Complexes, Antigen-Antibody,Complexes, Immune
D001704 Biopolymers Polymers synthesized by living organisms. They play a role in the formation of macromolecular structures and are synthesized via the covalent linkage of biological molecules, especially AMINO ACIDS; NUCLEOTIDES; and CARBOHYDRATES. Bioplastics,Bioplastic,Biopolymer
D012995 Solubility The ability of a substance to be dissolved, i.e. to form a solution with another substance. (From McGraw-Hill Dictionary of Scientific and Technical Terms, 6th ed) Solubilities

Related Publications

J Sancho, and E González, and F Rivera, and J F Escanero, and J Egido
February 1982, Journal of immunology (Baltimore, Md. : 1950),
J Sancho, and E González, and F Rivera, and J F Escanero, and J Egido
November 1989, American journal of kidney diseases : the official journal of the National Kidney Foundation,
J Sancho, and E González, and F Rivera, and J F Escanero, and J Egido
December 1986, American journal of kidney diseases : the official journal of the National Kidney Foundation,
J Sancho, and E González, and F Rivera, and J F Escanero, and J Egido
December 1984, Journal of immunology (Baltimore, Md. : 1950),
J Sancho, and E González, and F Rivera, and J F Escanero, and J Egido
February 1998, Journal of immunology (Baltimore, Md. : 1950),
J Sancho, and E González, and F Rivera, and J F Escanero, and J Egido
August 1987, Zentralblatt fur Veterinarmedizin. Reihe B. Journal of veterinary medicine. Series B,
J Sancho, and E González, and F Rivera, and J F Escanero, and J Egido
January 1974, Advances in experimental medicine and biology,
J Sancho, and E González, and F Rivera, and J F Escanero, and J Egido
February 1986, Clinica chimica acta; international journal of clinical chemistry,
J Sancho, and E González, and F Rivera, and J F Escanero, and J Egido
July 1987, Clinical and experimental immunology,
J Sancho, and E González, and F Rivera, and J F Escanero, and J Egido
May 1985, Clinical and experimental immunology,
Copied contents to your clipboard!